SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-035419
Filing Date
2024-03-22
Accepted
2024-03-22 16:42:12
Documents
16
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A inva-20231231.htm   iXBRL 10-K/A 271554
2 EX-23.3 inva-ex23_3.htm EX-23.3 2858
3 EX-31.1 inva-ex31_1.htm EX-31.1 13666
4 EX-31.2 inva-ex31_2.htm EX-31.2 13005
5 EX-32 inva-ex32.htm EX-32 14273
6 EX-99.1 inva-ex99_1.htm EX-99.1 723545
  Complete submission text file 0000950170-24-035419.txt   5029987

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT inva-20231231.xsd EX-101.SCH 2726588
20 EXTRACTED XBRL INSTANCE DOCUMENT inva-20231231_htm.xml XML 11223
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30319 | Film No.: 24775863
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)